EcoDrugPlus

Cyclin Dependent Kinase 7

Ensembl ID : ENSNGAG00000000676
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSNGAG00000018177
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSNGAG00000010412
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSNGAG00000023987
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSNGAG00000020319
Gene Symbol: LOC103747274
3 Cross references
207 Possible Orthologues:

Cytochrome P450 3a11-Like

Ensembl ID : ENSNGAG00000010294
Gene Symbol: LOC103726479
2 Cross references
637 Possible Orthologues:

Cytochrome P450 3a25-Like

Ensembl ID : ENSNGAG00000000778
Gene Symbol: LOC103726480
2 Cross references
629 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSNGAG00000011391
Gene Symbol: DGAT1
3 Cross references
260 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSNGAG00000018704
Gene Symbol: DHFR
3 Cross references
353 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSNGAG00000014011
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSNGAG00000010583
Gene Symbol: DPYD
3 Cross references
220 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSNGAG00000024181
Gene Symbol: DPP4
3 Cross references
282 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).